Chardan Capital Markets acts as Sole Placement Agent in $10 Million Securities Purchase

Friday, August 17, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Aug. 17, 2018 /PRNewswire/ -- Chardan, a global investment bank, announced today that the firm acted as sole placement

agent in Krystal Biotech, Inc.'s (NASDAQ: KRYS) securities purchase agreement with Frazier Healthcare Partners for the private placement of 625,000 shares at $16 per share. The private placement will yield gross proceeds
of $10 million.

"We're pleased to have partnered with Krystal Biotech to support the firm's efforts to continue its impressive research in dermatological diseases," said Jonas Grossman, President of Chardan. "Our experience in the space allowed us to find the capital needed to support this growth and we're looking forward to working with the team at Krystal to support future advancements."

Chardan has participated in advisory and capital raising transactions totaling more than $2 billion in 2018.

About Chardan Capital Markets

Chardan provides a full suite of Global Investment Banking services designed for emerging growth companies. Our full range of services includes capital raising, merger and acquisition advisory, strategic advisory, equity research, institutional trading and market making. Headquartered in New York City, Chardan is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: FINRA, SIPC, NASDAQ and the NYSE Arca, Inc.

To learn more about Chardan, visit www.chardan.com

Media Contact: Emily Levine, Chardan Capital Markets elevine@chardan.com (646) 465-9018

Tom Rozycki, Prosek Partners trozycki@prosek.com(646) 503-5657

Cision View original content:http://www.prnewswire.com/news-releases/chardan-capital-markets-acts-as-sole-placement-agent-in-10-million-securities-purchase-300698844.html

SOURCE Chardan Capital Markets, LLC



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store